HyClone™ Super Low IgG Fetal Bovine Serum (FBS), US origin
For use in monoclonal antibody production, virus propagation, and immunoassay procedures
HyClone™ Super Low IgG Fetal Bovine Serum (FBS), US origin
For use in monoclonal antibody production, virus propagation, and immunoassay procedures
Choose your product
1. Pack size
2. Variant
HyClone™ super low IgG FBS, U.S. origin, 100 mL
HyClone™ super low IgG FBS, U.S. origin, 100 mL
SH30898.02
Stock on request
Price includes standard shipping and handling
Overview
HyClone™ Super Low IgG Fetal Bovine Serum (FBS), US origin is designed for applications where extremely low levels of inherent bovine IgG are required. Super Low IgG FBS has been chromatographically treated to reduce IgG levels to less than 5 µg/mL, while still retaining excellent cell growth properties.
- Sourced in the US
- Complete traceability is provided back to the original source, as certified by the International Serum Industry Association (ISIA).
- 40 nm filtered
Purchase orders with specific lot requests, quoted reserves, and/or call-off orders should be submitted through Customer Service.
Additional treatments are available: HyClone™ FBS heat inactivated (HI) and HyClone™ FBS irradiated (IR). Additional testing, including EMEA-conforming testing, is also available.
Product specifications
Showing 7 products
HyClone™ super low IgG FBS, U.S. origin, 500 mL
SH30898.03
In stock2334 available
HyClone™ super low IgG FBS, U.S. origin, heat-inactivated, 500 mL
SH30898.03HI
In stock18 available
HyClone™ super low IgG FBS, U.S. origin, irradiated 25-40kGy, heat-inactivated, 500 mL
SH30898.03IH25-40
Selling fast1 available
HyClone™ super low IgG FBS, U.S. origin, 50 mL
SH30898.01
Stock on request
HyClone™ super low IgG FBS, U.S. origin, 100 mL
SH30898.02
Stock on request
HyClone™ super low IgG FBS, U.S. origin, heat-inactivated, 100 mL
SH30898.02HI
Stock on request
HyClone™ super low IgG FBS, U.S. origin, irradiated 25-40kGy, 500 mL
SH30898.03IR25-40
Stock on request
Product availability is not guaranteed and subject to change.
